Pharmaceutical News

RSS
New data shows safety and efficacy of biosimilar infliximab treatment in IBD patients

New data shows safety and efficacy of biosimilar infliximab treatment in IBD patients

Omega-3 fatty acids improve cognitive flexibility in older adults at risk of late-onset Alzheimer's disease

Omega-3 fatty acids improve cognitive flexibility in older adults at risk of late-onset Alzheimer's disease

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

New UCLA study finds Naltrexone drug as promising treatment for methamphetamine addiction

Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Twin Cities Orthopedics joins Deterra partnership program to reduce prescription drug abuse and misuse

Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Short course of oral steroids unlikely to provide much benefit for patients with acute sciatica

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Two-drug combination improves lung function in some cystic fibrosis patients

Two-drug combination improves lung function in some cystic fibrosis patients

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

New study reveals that 'imperfect drug penetration' can accelerate pathogens' resistance

New study reveals that 'imperfect drug penetration' can accelerate pathogens' resistance

Blood-thinning treatment safe for patients with brain metastases

Blood-thinning treatment safe for patients with brain metastases

OSU researchers find promising approach to treating epithelial cancer

OSU researchers find promising approach to treating epithelial cancer

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

Monash University-led researchers call for HCV patients to gain improved access to effective drugs

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Lab M demonstrates quality with compliance to ISO 11133:2014

Lab M demonstrates quality with compliance to ISO 11133:2014

Regular use of aspirin may slow the progression of early emphysema, new research shows

Regular use of aspirin may slow the progression of early emphysema, new research shows

Endo Announces Updated XIAFLEX® Label in Patients with Dupuytren’s Contracture

Endo Announces Updated XIAFLEX® Label in Patients with Dupuytren’s Contracture

Study compares effectiveness of treatments for metastatic non-clear cell kidney cancers

Study compares effectiveness of treatments for metastatic non-clear cell kidney cancers

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

Combination of contraceptive and cholesterol-lowering drugs kills cancer cells in a new way

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.